# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001683168-21-000974
Filing Date
2021-03-17
Accepted
2021-03-17 07:50:42
Documents
21
Period of Report
2021-03-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | cns_8k.htm | 8-K | 16939
2 | INVESTOR PRESENTATION | cns_ex9901.htm | EX-99.1 | 27291
3 | GRAPHIC | image_001.jpg | GRAPHIC | 178128
4 | GRAPHIC | image_002.jpg | GRAPHIC | 155345
5 | GRAPHIC | image_003.jpg | GRAPHIC | 244172
6 | GRAPHIC | image_004.jpg | GRAPHIC | 140155
7 | GRAPHIC | image_005.jpg | GRAPHIC | 154626
8 | GRAPHIC | image_006.jpg | GRAPHIC | 149736
9 | GRAPHIC | image_007.jpg | GRAPHIC | 208141
10 | GRAPHIC | image_008.jpg | GRAPHIC | 244840
11 | GRAPHIC | image_009.jpg | GRAPHIC | 198835
12 | GRAPHIC | image_010.jpg | GRAPHIC | 178453
13 | GRAPHIC | image_011.jpg | GRAPHIC | 257056
14 | GRAPHIC | image_012.jpg | GRAPHIC | 189139
15 | GRAPHIC | image_013.jpg | GRAPHIC | 224364
16 | GRAPHIC | image_014.jpg | GRAPHIC | 215017
17 | GRAPHIC | image_015.jpg | GRAPHIC | 234488
18 | GRAPHIC | image_016.jpg | GRAPHIC | 220841
19 | GRAPHIC | image_017.jpg | GRAPHIC | 237893
20 | GRAPHIC | image_018.jpg | GRAPHIC | 141867
21 | GRAPHIC | image_019.jpg | GRAPHIC | 174662
| Complete submission text file | 0001683168-21-000974.txt |  | 5209540

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 21748455
SIC: 2834 Pharmaceutical Preparations